title: Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells.
abstract: In order to enhance recombinant protein productivity in animal cells, we developed the oncogene activated production (OAP) system. The OAP system is based on the premise that oncogenes are able to enhance promoter activity. To this end, we constructed reported plasmids by fusing various promoters to the human interleukin-6 (hIL-6) cDNA, and the effector plasmids by inserting individual oncogenes, for example c-myc, c-fos, v-jun, v-myb and c-Ha-ras, downstream from the human cytomegalovirus immediate early (CMV) promoter. Results of transient expression experiments with BHK-21 cells suggest that the CMV promoter is the most potent promoter examined and that the ras product is able to transactivate the beta-actin, CMV and SR alpha promoters. Recombinant BHK-21 cells producing hIL-6 under the control of the CMV promoter were contransfected with the ras oncogene and dihydrofolate reductase gene, then selected with 50 nM methotrexate to coamplify the ras oncogene. We were able to rapidly establish a stable and highly productive clone which exhibited a 35-times higher production rate as compared to the control value.
authors.affiliation: Laboratory of Cellular Regulation Technology, Graduate School of Genetic Resources Technology, Kyushu University, Fukuoka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yano
authors.forename: K
authors.initials: K
authors.lastname: Teruya
authors.forename: S
authors.initials: S
authors.lastname: Shirahata
authors.forename: J
authors.initials: J
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Osada
authors.forename: H
authors.initials: H
authors.lastname: Tachibana
authors.forename: H
authors.initials: H
authors.lastname: Ohashi
authors.forename: E H
authors.initials: EH
authors.lastname: Kim
authors.forename: H
authors.initials: H
authors.lastname: Murakami
mesh_terms: D000199:Actins / Q000235:genetics; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003587:Cytomegalovirus / Q000235:genetics*; D005786:Gene Expression Regulation; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D007668:Kidney / Q000166:cytology; D008727:Methotrexate / Q000494:pharmacology; D009857:Oncogenes / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics*; D011994:Recombinant Proteins / Q000096:biosynthesis*; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics; D015533:Transcriptional Activation; D014162:Transfection; D018631:ras Proteins / Q000502:physiology
chemical_list: D000199:Actins; D015850:Interleukin-6; D011994:Recombinant Proteins; D013762:Tetrahydrofolate Dehydrogenase; D018631:ras Proteins; D008727:Methotrexate